CS70891A2 - Substituted purines, method of their production and their application as antiviral agents - Google Patents

Substituted purines, method of their production and their application as antiviral agents

Info

Publication number
CS70891A2
CS70891A2 CS91708A CS70891A CS70891A2 CS 70891 A2 CS70891 A2 CS 70891A2 CS 91708 A CS91708 A CS 91708A CS 70891 A CS70891 A CS 70891A CS 70891 A2 CS70891 A2 CS 70891A2
Authority
CS
Czechoslovakia
Prior art keywords
ch2ph
alkyl
dialkylamino
production
application
Prior art date
Application number
CS91708A
Other languages
Czech (cs)
Inventor
Gerhard Dr Jahne
Manfred Dr Rosner
Irvin Dr Winkler
Matthias Dr Helsberg
Thomas Dr Scholl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CS70891A2 publication Critical patent/CS70891A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Purine derivs. of formula (I) and their salts are new. R1 = H, halo, NH3, OH, 1-6C alkoxy, -O-CH2Ph, -OPh, SH, 1-6C alkylthio, -S-CH2Ph, -SPh, NH2, 1-6C alkylamino, -NH-CH2Ph, -NH-Ph, 2-12C dialkylamino, -N(CH2Ph)2, cyclic dialkylamino, -N(Ph)2, 1-8C acylamino, 2-16C diacylamino, (N-alkyl-2-pyrrolidin-yliden)amino or 2-10C dialkylaminomethylidenamino; R2 = H, halo, N3, OH, SH, NH2, 1-6C alkylamino, 2-12C dialkylamino, -NH-CH2Ph, -N-(CH2Ph)2, cyclic dialkylamino, -NH-Ph, -N(Ph)2, 1-8C acylamino or thioacylamino, 2-16C diacylamino or di(thioacyl)amino; R3 = H, 1-6C alkyl (opt. substd.) or R8, where R8 is a phosphate ester-contg. gp.; R4 = H, 1-6C alkyl, OH, SH, NH2, halo, N3, 1-6C alkoxy, alkylthio or alkylamino, 2-12C dialkylamino, -O-CH2Ph, -S-CH2Ph, -NH-CH2Ph, -N(CH2Ph)2, -NHPh, -N(Ph)2, -OPh, -SPh, 1-8C acyloxy, 1-8C acylthio, 1-8C acylamino, 2-16C diacylamino, -O-(1-4C alkyl)-P(O)(OR6)(OR7) or -O(1-4C alkyl)-P(1-6C alkyl)(=O)(OR6); R5 = H, 1-6C alkyl (opt. substd.). A number of provisos are given in the specification.
CS91708A 1990-03-20 1991-03-18 Substituted purines, method of their production and their application as antiviral agents CS70891A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4008858A DE4008858A1 (en) 1990-03-20 1990-03-20 SUBSTITUTED PURINE, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS AN ANTIVIRAL AGENT

Publications (1)

Publication Number Publication Date
CS70891A2 true CS70891A2 (en) 1991-11-12

Family

ID=6402601

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91708A CS70891A2 (en) 1990-03-20 1991-03-18 Substituted purines, method of their production and their application as antiviral agents

Country Status (19)

Country Link
EP (1) EP0452680B1 (en)
JP (1) JP3146423B2 (en)
KR (1) KR910016751A (en)
CN (1) CN1054982A (en)
AT (1) ATE144984T1 (en)
AU (1) AU644414B2 (en)
CA (1) CA2038589A1 (en)
CS (1) CS70891A2 (en)
DE (2) DE4008858A1 (en)
DK (1) DK0452680T3 (en)
ES (1) ES2093651T3 (en)
FI (1) FI911310A7 (en)
GR (1) GR3021591T3 (en)
HU (1) HUT57764A (en)
IE (1) IE910908A1 (en)
IL (1) IL97586A0 (en)
NO (1) NO911081L (en)
PT (1) PT97080A (en)
ZA (1) ZA912015B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210221A1 (en) * 1992-03-28 1993-09-30 Hoechst Ag Carboxylic acid esters of 2-amino-7- (1,3-dihydroxy-2-propoxymethyl) purine, their preparation and their use
EP0589335B1 (en) * 1992-09-24 2003-06-18 Hoechst Aktiengesellschaft N1-Substituted- (1H)-1,2,3-Triazolo (4,5-d) pyrimidines, process for their preparation and their use as antiviral means
DE4311801A1 (en) * 1993-04-09 1994-10-13 Hoechst Ag New carboxylic acid esters of 2-amino-7- (1,3-dihydroxy-2-propoxymethyl) purine, their preparation and their use
DE19536164A1 (en) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Improved Process for the Production of 9 - [(2-Hydroxyethoxy) methyl] guanine (Acyclovir)
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
FR2793794B1 (en) * 1999-05-21 2001-07-27 Hoechst Marion Roussel Inc NOVEL PURINE DERIVATIVES, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NEW USE
PE20030008A1 (en) 2001-06-19 2003-01-22 Bristol Myers Squibb Co DUAL INHIBITORS OF PDE 7 AND PDE 4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
DE3627024A1 (en) * 1985-09-24 1987-04-02 Hoechst Ag 2-AMINOPURINS SUBSTITUTED IN 6 AND 9 POSITIONS, THEIR USE, MEDICINAL PRODUCTS CONTAINING THESE PURINES AND METHOD FOR THE PRODUCTION OF THE PURINS
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
PT97080A (en) 1991-11-29
CA2038589A1 (en) 1991-09-21
EP0452680B1 (en) 1996-11-06
FI911310L (en) 1991-09-21
ATE144984T1 (en) 1996-11-15
ZA912015B (en) 1991-12-24
CN1054982A (en) 1991-10-02
ES2093651T3 (en) 1997-01-01
DE59108319D1 (en) 1996-12-12
EP0452680A1 (en) 1991-10-23
GR3021591T3 (en) 1997-02-28
AU644414B2 (en) 1993-12-09
DE4008858A1 (en) 1991-09-26
DK0452680T3 (en) 1997-04-07
HU910928D0 (en) 1991-10-28
JP3146423B2 (en) 2001-03-19
NO911081D0 (en) 1991-03-19
IL97586A0 (en) 1992-06-21
FI911310A7 (en) 1991-09-21
KR910016751A (en) 1991-11-05
IE910908A1 (en) 1991-09-25
HUT57764A (en) 1991-12-30
JPH04217984A (en) 1992-08-07
FI911310A0 (en) 1991-03-18
NO911081L (en) 1991-09-23
AU7351491A (en) 1991-09-26

Similar Documents

Publication Publication Date Title
YU218788A (en) Process for preparing substituted propan-phosphinic acids
CA2136622A1 (en) Phosphotriester-type biologically active compounds
CS70891A2 (en) Substituted purines, method of their production and their application as antiviral agents
HU912253D0 (en) Process for the production of purinyl-phosphonic acid derivatives
IE872650L (en) Imidazopyridine derivatives, their production, and¹pharmaceutical compositions containing them
HUT50820A (en) Process for producing purine derivatives with antiviral effect
PL244141A1 (en) Process for preparing derivatives of purine
EP0310673A4 (en) 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use
EP0371139A4 (en) 6-substituted acyclicpyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients
GR3018105T3 (en) Antiviral purine derivatives and process for their preparation.
AU627939B2 (en) 9-(2,2-dicarboalkoxycyclopropyl) purine process
PL276046A1 (en) Method for manufacturing new derivatives of purine
ZA962981B (en) Nitric esters from derivatives of 2-(2,6-dihalophenylamino) phenylacetoxyacetic acid and their preparation process
HUT65865A (en) Process for producing 2-amino-6,7-dihydroxy-4-thia-heptanic-acid derivatives
HUT71797A (en) Cyclohexane derivatives, process for producing them and their use for the treatment of disease
DE69309341D1 (en) Process for the production of carbohydrate surfactants and their precursors
WO2008071689A3 (en) Process for the manufacture of alkylamino alkylene phosphonic acids